This study investigated the relationship between cardiac magnetic resonance (CMR) T1 mapping parameters and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in non-ischaemic dilated cardiomyopathy (DCM) patients. The results showed that, in DCM, a non-linear relationship existed between NT-proBNP and septal native T1, indicating a complex relationship between the secretion of NT-proBNP and myocardial diffuse fibrosis. When NT-proBNP is greater than the inflection point(1105 pg/ml), NT-proBNP may provide additional value for the judgment of myocardial diffuse fibrosis.
1. Reichart D, Magnussen C, Zeller T, Blankenberg S. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature. J Intern Med 2019; 286: 362-372.
2. Seferovic PM, Polovina MM, Coats AJS. Heart failure in dilated non-ischaemic cardiomyopathy. Eur Heart J Suppl 2019; 21: M40-M43.
3. Mandawat A, Chattranukulchai P, Mandawat A et al. Progression of Myocardial Fibrosis in Nonischemic DCM and Association With Mortality and Heart Failure Outcomes. JACC Cardiovasc Imaging 2021; 14: 1338-1350.
4. Kiaos A, Antonakaki D, Bazmpani MA et al. Prognostic value of cardiovascular magnetic resonance T1 mapping techniques in non-ischemic dilated cardiomyopathy: A systematic review and meta-analysis. Int J Cardiol 2020; 312: 110-116.
5. Becker MAJ, Cornel JH, van de Ven PM et al. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis. JACC Cardiovasc Imaging 2018; 11: 1274-1284.
6. Messroghli DR, Moon JC, Ferreira VM et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 2017; 19: 75.
7. Nakagawa Y, Nishikimi T, Kuwahara K. Atrial and brain natriuretic peptides: Hormones secreted from the heart. Peptides 2019; 111: 18-25.
8. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
Variables with P values < 0.05 were included in multivariate analysis.
Abbreviations: AF: atrial fibrillation; BMI: body mass index; DBP: diastolic blood pressure; DM:diabetes mellitus; EF: ejection fraction; HR: heart rate; LV: left ventricular; MI ED mass index in end diastole; NT-proBNP: N-terminal pro-B-type natriuretic peptide; NYHA: New York Heart Association; SBP: systolic blood pressure.
NT-proBNP were log2 transformed for fitting the piecewise binary linear regression model. Analysis was adjusted for sex, hypertension, smoker, alcohol user, DBP and BMI.
Abbreviations: BMI: body mass index; CI: confidence interval; DBP: diastolic blood pressure; NT-proBNP: N-terminal pro-B-type natriuretic peptide.
Fig.1 A region of interest (ROI) was drawn in the midinterventricular septum of the medium section of left ventricle (LV) to evaluate the septal native T1 (A) and septal post T1(B). C is the corresponding color image of A. D is the corresponding color image of B.
Fig.2 The unadjusted relationship between log2 transformed NT-proBNP and septal native T1 (A), and adjusted restricted cubic spline plot of the association between NT-proBNP and septal native T1 (B). Analysis was adjusted for sex, hypertension, smoker, alcohol user, DBP and BMI.
Abbreviations: BMI: body mass index; DBP: diastolic blood pressure; NT-proBNP: N-terminal pro-B-type natriuretic peptide.